Cargando…

Factors of early protective action of live influenza vaccine combined with recombinant bacterial polypeptides against homologous and heterologous influenza infection

We are developing an associated vaccine based on live influenza vaccine (LAIV) and streptococcal recombinant peptides. The recombinant group B streptococcus (GBS) peptides P6 and ScaAB demonstrated a distinguished immunomodulating effect in THP-1 cells. The increase in IFN 1-alpha expression after S...

Descripción completa

Detalles Bibliográficos
Autores principales:	Desheva, Yulia A., Leontieva, Galina F., Kramskaya, Tatiana A., Landgraf, Galina O., Sychev, Ivan A., Rekstin, Andrey R., Suvorov, Alexander N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6365543/ https://www.ncbi.nlm.nih.gov/pubmed/30839941 http://dx.doi.org/10.1016/j.heliyon.2019.e01154

Ejemplares similares

Live Influenza Vaccine Provides Early Protection against Homologous and Heterologous Influenza and May Prevent Post-Influenza Pneumococcal Infections in Mice
por: Desheva, Yulia, et al.
Publicado: (2022)

Associated virus-bacterial vaccine based on seasonal LAIV and S. pneumoniae chimeric peptide provide protection against post-influenza pneumococcal infection in mouse model
por: Desheva, Yulia, et al.
Publicado: (2022)

Prevention of Influenza A(H7N9) and Bacterial Infections in Mice Using Intranasal Immunization With Live Influenza Vaccine and the Group B Streptococcus Recombinant Polypeptides
por: Desheva, Yulia A, et al.
Publicado: (2017)

Mucosal vaccine based on attenuated influenza virus and the group B Streptococcus recombinant peptides protected mice from influenza and S. pneumoniae infections
por: Desheva, Yulia, et al.
Publicado: (2019)

Evaluation in Mouse Model of Combined Virus-bacterial Vaccine Based on Attenuated Influenza A(H7N3) Virus and the Group B Streptococcus Recombinant Polypeptides
por: Desheva, Yulia A., et al.
Publicado: (2016)

Developing a Live Probiotic Vaccine Based on the Enterococcus faecium L3 Strain Expressing Influenza Neuraminidase
por: Desheva, Yulia, et al.
Publicado: (2021)

Combined immunization with attenuated live influenza vaccine and chimeric pneumococcal recombinant protein improves the outcome of virus-bacterial infection in mice
por: Kramskaya, T., et al.
Publicado: (2019)

Construction of the Enterococcal Strain Expressing Immunogenic Fragment of SARS-Cov-2 Virus
por: Suvorov, Alexander, et al.
Publicado: (2022)

Anti-neuraminidase antibodies against pandemic A/H1N1 influenza viruses in healthy and influenza-infected individuals
por: Desheva, Yulia, et al.
Publicado: (2018)

A Live Probiotic Vaccine Prototype Based on Conserved Influenza a Virus Antigens Protect Mice against Lethal Influenza Virus Infection
por: Mezhenskaya, Daria, et al.
Publicado: (2021)

Development of experimental pneumococcal vaccine for mucosal immunization
por: Gupalova, Tatiana, et al.
Publicado: (2019)

Live Attenuated Influenza H7N3 Vaccine is Safe, Immunogenic and Confers Protection in Animal Models
por: Rekstin, Andrey, et al.
Publicado: (2014)

SARS-CoV-2 Spike Protein-Expressing Enterococcus for Oral Vaccination: Immunogenicity and Protection
por: Suvorov, Alexander, et al.
Publicado: (2023)

Pilot Study Results on Antibodies to the S- and N-Proteins of SARS-CoV-2 in Paired Sera from COVID-19 Patients with Varying Severity
por: Desheva, Yulia, et al.
Publicado: (2023)

Autoprobiotics as an Approach for Restoration of Personalised Microbiota
por: Suvorov, Alexander, et al.
Publicado: (2018)

Mast cell degranulation and histamine release during A/H5N1 influenza infection in influenza-sensitized mice
por: Desheva, Yulia, et al.
Publicado: (2020)

Study of Antibodies to Influenza Neuraminidase N2
por: Desheva, Yulia, et al.
Publicado: (2022)

Safety and immunogenicity of live attenuated influenza reassortant H5 vaccine (phase I–II clinical trials)
por: Rudenko, Larisa, et al.
Publicado: (2008)

Study of Neuraminidase-Inhibiting Antibodies in Clinical Trials of Live Influenza Vaccines
por: Desheva, Yulia, et al.
Publicado: (2020)

Assessment of trivalent live influenza vaccines in MDCK cell line
por: Landgraf, G., et al.
Publicado: (2021)

Immunogenicity and Cross Protection in Mice Afforded by Pandemic H1N1 Live Attenuated Influenza Vaccine Containing Wild-Type Nucleoprotein
por: Rekstin, Andrey, et al.
Publicado: (2017)

Development of experimental GBS vaccine for mucosal immunization
por: Gupalova, T., et al.
Publicado: (2018)

Analysis of gene expression in monocytes of immunized pigs after infection with homologous or heterologous African swine fever virus
por: Kholod, Natalia, et al.
Publicado: (2022)

Intradermal vaccination of live attenuated influenza vaccine protects mice against homologous and heterologous influenza challenges
por: Lee, Andrew Chak-Yiu, et al.
Publicado: (2021)

Sequential Immunization with Universal Live Attenuated Influenza Vaccine Candidates Protects Ferrets against a High-Dose Heterologous Virus Challenge
por: Isakova-Sivak, Irina, et al.
Publicado: (2019)

Exploring heterologous prime-boost vaccination approaches to enhance influenza control in pigs
por: Li, Chong, et al.
Publicado: (2020)

QUANTITATIVE ASPECTS OF HOMOLOGOUS AND HETEROLOGOUS ACTIVE IMMUNITY TO STRAINS OF THE VIRUS OF EPIDEMIC INFLUENZA
por: Eaton, Monroe D., et al.
Publicado: (1940)

Determination of H5N1 vaccine potency using reference antisera from heterologous strains of influenza
por: Vodeiko, Galina M., et al.
Publicado: (2011)

Pair formation and promiscuity of cytokeratins: formation in vitro of heterotypic complexes and intermediate-sized filaments by homologous and heterologous recombinations of purified polypeptides
Publicado: (1985)

Corrigendum to “Assessment of trivalent live influenza vaccines in MDCK cell line” [MethodsX 8 (2021) 101442]
por: Landgraf, G., et al.
Publicado: (2021)

Study of Antibody-Dependent Reactions of Mast Cells In Vitro and in a Model of Severe Influenza Infection in Mice
por: Mamontov, Andrey, et al.
Publicado: (2021)

ACTION ON FIBROBLASTS OF EXTRACTS OF HOMOLOGOUS AND HETEROLOGOUS TISSUES
por: Carrel, Alexis, et al.
Publicado: (1923)

Serum strain-specific or cross-reactive neuraminidase inhibiting antibodies against pandemic А/California/07/2009(H1N1) influenza in healthy volunteers
por: Desheva, Yulia A, et al.
Publicado: (2015)

Stimulation of homologous recombination in plants expressing heterologous recombinases
por: Barakate, Abdellah, et al.
Publicado: (2020)

No observed effect of homologous recombination on influenza C virus evolution
por: Han, Guan-Zhu, et al.
Publicado: (2010)

Guidelines for Identifying Homologous Recombination Events in Influenza A Virus
por: Boni, Maciej F., et al.
Publicado: (2010)

Evidence of intra-segmental homologous recombination in influenza A virus
por: Hao, Weilong
Publicado: (2011)

Universal Live-Attenuated Influenza Vaccine Candidates Expressing Multiple M2e Epitopes Protect Ferrets against a High-Dose Heterologous Virus Challenge
por: Mezhenskaya, Daria, et al.
Publicado: (2021)

Immunogenicity of Three Different Influenza Vaccines against Homologous and Heterologous Strains in Nursing Home Elderly Residents
por: Baldo, Vincenzo, et al.
Publicado: (2010)

Longitudinal Analysis of Neuraminidase and Hemagglutinin Antibodies to Influenza A Viruses after Immunization with Seasonal Inactivated Influenza Vaccines
por: Sergeeva, Mariia V., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_j0rsi9ebl0tg3tlgh3721vueoc